ASH Letter to FDA and Intl Conference on Harmonization re Draft Guideline for Good Clinical Practice
Sep 05
2023
American Society of Hematology. (2023).
ASH Letter to FDA and Intl Conference on Harmonization re Draft Guideline for Good Clinical Practice.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-and-intl-conference-on-harmonization-re-draft-guideline-for-good-clinical-practice.
American Society of Hematology.
"ASH Letter to FDA and Intl Conference on Harmonization re Draft Guideline for Good Clinical Practice." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-and-intl-conference-on-harmonization-re-draft-guideline-for-good-clinical-practice
(label-accessed May 12, 2024).
"American Society of Hematology."
ASH Letter to FDA and Intl Conference on Harmonization re Draft Guideline for Good Clinical Practice, 12 May. 2024 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-and-intl-conference-on-harmonization-re-draft-guideline-for-good-clinical-practice.
